Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-19-000156

Director sold 16,024 shares at an average $24.80 ($397,373)

  • Director acquired 9,127 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

HIPP RAYMOND R · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-23 Exercise or conversion : show line 1 in the form +3,017 $11.60 $34,997 144,016 D
2019-08-23 Exercise or conversion : show line 2 in the form +3,333 $7.27 $24,231 147,349 D
2019-08-23 Exercise or conversion : show line 3 in the form +2,777 $9.11 $25,298 150,126 D
2019-08-23 Sale : show line 4 in the form −600 $25.02 $15,012 149,526 D
2019-08-26 Sale : show line 5 in the form −15,424 $24.79 $382,361 134,102 D
Open-market sales · 16,024 sh · avg $24.80 · $397,373

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-08-23 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,777 $9.11 2021-07-28 2,777 0 D
2019-08-23 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,333 $7.27 2022-05-25 6,667 3,334 D
2019-08-23 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,017 $11.60 2023-06-01 3,017 0 D
Loading xslF345X03/wf-form4_156694223006156.xml…